PREMIUM
Agric. & Environment
'Sh42b needed to commercialise anti-tick vaccine'
Research and further development of the vaccine needs to be amplified to full production for commercial levels.
Research and further development of the vaccine needs to be amplified to full production for commercial levels. (Courtesy)
By: NewVision Reporter, Journalists @NewVision
___________________
Authorities at Makerere University and Alfasan Uganda Ltd, a private pharma company, say they need at least sh42b to produce an anti-tick vaccine for commercialisation. Alfasan was